Skip to main content
Top

Predictors of futile recanalization in nonagenarians treated with mechanical thrombectomy: a multi-center observational study

  • Open Access
  • 16-05-2024
  • Thrombectomy
  • Original Communication
Published in:

Abstract

Background

There is a lack of data regarding patients aged 90 years or older undergoing mechanical thrombectomy and their predictors of futile recanalization.

Aims

We sought to evaluate the predictors of futile recanalization in patients ≥ 90 years with large vessel occlusion undergoing mechanical thrombectomy.

Methods

This multi-center observational retrospective study included patients ≥ 90 years consecutively treated with mechanical thrombectomy in four thrombectomy capable centers between January 1st, 2016 and 30th March 2023. Futile recanalization was defined as large vessel occlusion patients experiencing a 90-day poor outcome (mRS 3–6) despite successful recanalization (mTICI ≥ 2b) after mechanical thrombectomy.

Results

Our cohort included 139 patients ≥ 90 years with acute ischemic stroke due to anterior circulation large vessel occlusion treated with mechanical thrombectomy. One hundred seventeen of one hundred thirty-nine patients ≥ 90 years who achieved successful recanalization were included in the analysis (seventy-six female (64.9%)), of whom thirty-one (26.49%) experienced effective recanalization and eighty-six (73.51%) experienced futile recanalization. Patients with futile recanalization had higher NIHSS on admission (p < 0.001); they were less frequently treated with intravenous thrombolysis (p = 0.048), had more often general anesthesia (p = 0.011), and longer door to groin puncture delay (p = 0.002). Univariable regression analysis showed that use of intravenous thrombolysis (0.29, 95% CI 0.02–0.79, p = 0.034) and site of occlusion distal vs proximal (0.34, 95% CI 0.11–0.97, p = 0.044) were associated with reduced probability of futile recanalization while NIHSS on admission (1.29, 95% CI 1.16–1.45, p < 0.001), NIHSS at 24 h (1.15, 95% CI 1.07–1.25, p = 0.002), type of anesthesia used (4.18, 95% CI 1.57–11.08, p = 0.004), and door to groin puncture time (1.02, 95% CI 1.00–1.05, p = 0.005) were associated with increased probability of futile recanalization. Multivariable regression analysis showed that use of intravenous thrombolysis (0.44, 95% CI 0.09–0.88, p = 0.039) was associated with reduced probability of futile recanalization.

Conclusion

Our study seems to suggest that mechanical thrombectomy with intravenous thrombolysis is associated with reduced probability of futile recanalization in a multi-center cohort of patients aged 90 years or older.
Title
Predictors of futile recanalization in nonagenarians treated with mechanical thrombectomy: a multi-center observational study
Authors
Lucio D’Anna
Giovanni Merlino
Michele Romoli
Liqun Zhang
Caterina Del Regno
Mohammed Aggour
Viva Levee
Matteo Foschi
Massimo Sponza
Francesco Toraldo
Razan Algazlan
Maria Ruggiero
Marco Longoni
Kyriakos Lobotesis
Samir Abu-Rumeileh
Daniele Bagatto
Nina Mansoor
Gian Luigi Gigli
Mariarosaria Valente
Soma Banerjee
Publication date
16-05-2024
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 8/2024
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-024-12428-8
This content is only visible if you are logged in and have the appropriate permissions.
This content is only visible if you are logged in and have the appropriate permissions.

Case challenge: neuroimaging in Alzheimer disease (Link opens in a new window)

Put your decision-making and interpretation skills into practice with these six cases focusing on different presentations. Can you choose the optimal PET tracer, accurately interpret the results, and advise on next steps?

This content is intended for healthcare professionals outside of the UK.

Independent Medical Education Grant:
  • Lilly
Start now Link opens in a new window
Image Credits
Navigating neuroimaging in Alzheimer’s care: Practical applications and strategies for integration/© Springer Health+ IME